ATE433325T1 - Multimerer, rekombinanter urease impfstoff - Google Patents

Multimerer, rekombinanter urease impfstoff

Info

Publication number
ATE433325T1
ATE433325T1 AT96913166T AT96913166T ATE433325T1 AT E433325 T1 ATE433325 T1 AT E433325T1 AT 96913166 T AT96913166 T AT 96913166T AT 96913166 T AT96913166 T AT 96913166T AT E433325 T1 ATE433325 T1 AT E433325T1
Authority
AT
Austria
Prior art keywords
compositions
helicobacter
recombinant urease
methods
multimeric recombinant
Prior art date
Application number
AT96913166T
Other languages
English (en)
Inventor
Cynthia Lee
Thomas Monath
Samuel Ackerman
William Thomas
Gopalan Soman
Harold Kleanthous
Richard Weltzin
Jacques Pappo
Thomas Ermak
Farshad Guirakhoo
Hitesh Bhagat
Ilene Sussman
Original Assignee
Merieux Oravax Snc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Oravax Snc filed Critical Merieux Oravax Snc
Application granted granted Critical
Publication of ATE433325T1 publication Critical patent/ATE433325T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT96913166T 1995-04-28 1996-04-25 Multimerer, rekombinanter urease impfstoff ATE433325T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43104195A 1995-04-28 1995-04-28
US56812295A 1995-12-06 1995-12-06
PCT/US1996/005800 WO1996033732A1 (en) 1995-04-28 1996-04-25 Multimeric, recombinant urease vaccine

Publications (1)

Publication Number Publication Date
ATE433325T1 true ATE433325T1 (de) 2009-06-15

Family

ID=27028868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913166T ATE433325T1 (de) 1995-04-28 1996-04-25 Multimerer, rekombinanter urease impfstoff

Country Status (15)

Country Link
EP (1) EP0831892B1 (de)
JP (1) JPH11504633A (de)
KR (1) KR19990008155A (de)
AT (1) ATE433325T1 (de)
AU (1) AU723063B2 (de)
BR (1) BR9609871A (de)
CA (1) CA2219201A1 (de)
CZ (1) CZ342697A3 (de)
DE (1) DE69637947D1 (de)
HU (1) HUP9801266A3 (de)
MX (1) MX9708319A (de)
NO (1) NO974969L (de)
NZ (1) NZ307017A (de)
PL (1) PL185013B1 (de)
WO (1) WO1996033732A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
DE19521314A1 (de) * 1995-06-12 1996-12-19 Max Planck Gesellschaft Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid
EP0835928A1 (de) * 1996-10-11 1998-04-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Helicobacter Pylori Lebendimpfstoff
EP1021458A4 (de) * 1996-11-14 2001-12-12 Merieux Oravax Helicobacter-polypeptide und entsprechende polynukleotidmoleküle
US6248551B1 (en) 1997-03-28 2001-06-19 Institut Pasteur Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
GB9718616D0 (en) * 1997-09-02 1997-11-05 Queen Mary & Westfield College Oral vaccine
US5985631A (en) * 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
EP1105159A2 (de) 1998-06-19 2001-06-13 Mérieux Oravax Lt und ct in verfahren zur parenteralen immunisierung gegen helicobacter-infektionen
US6190667B1 (en) 1998-06-30 2001-02-20 Institut Pasteur Methods of inhibiting Helicobacter pylori
AU8464398A (en) * 1998-07-16 2000-02-07 Cheil Jedang Corporation Urease based vaccine against (helicobacter) infection
ATE369875T1 (de) * 2002-01-15 2007-09-15 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Orale vakzinierung mit nackten tumor-antigen- mimotopen
DE50307169D1 (de) * 2002-01-15 2007-06-14 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh ORALE VAKZINIERUNG MIT DEM TUMOR-ANTIGEN-MIMOTOP Gln-Met-Trp-Ala-Pro-Gln-Trp-Gly-Pro-Asp
WO2005113603A1 (en) * 2004-05-18 2005-12-01 Universite De Lausanne Eradication of helicobacter infection by activation of stomach mast cells
CN100460013C (zh) * 2006-09-05 2009-02-11 重庆康卫生物科技有限公司 口服重组幽门螺杆菌疫苗及其制备方法
CN100535119C (zh) * 2006-11-07 2009-09-02 上海交通大学医学院附属第九人民医院 一种制备唾液链球菌尿素酶基因的方法
CN101955545B (zh) * 2010-09-07 2012-07-04 四川万可泰生物技术有限责任公司 一种多靶点重组基因及其蛋白在防治幽门螺旋杆菌感染中的应用
CN113433087A (zh) * 2021-06-22 2021-09-24 中南大学 一种尿素浓度快速检测方法及检测传感器和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
US5972336A (en) * 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
FR2732605B1 (fr) * 1995-04-07 1997-05-16 Pasteur Merieux Serums Vacc Composition destinee a l'induction d'une reponse immunitaire mucosale

Also Published As

Publication number Publication date
HUP9801266A3 (en) 1999-07-28
NO974969L (no) 1997-12-23
JPH11504633A (ja) 1999-04-27
KR19990008155A (ko) 1999-01-25
MX9708319A (es) 1998-08-30
EP0831892A4 (de) 2002-06-26
AU723063B2 (en) 2000-08-17
EP0831892A1 (de) 1998-04-01
EP0831892B1 (de) 2009-06-10
HUP9801266A2 (hu) 1998-08-28
PL323048A1 (en) 1998-03-02
AU5576496A (en) 1996-11-18
CA2219201A1 (en) 1996-10-31
NZ307017A (en) 1999-07-29
CZ342697A3 (cs) 1998-06-17
DE69637947D1 (de) 2009-07-23
PL185013B1 (pl) 2003-01-31
BR9609871A (pt) 2000-03-28
WO1996033732A1 (en) 1996-10-31
NO974969D0 (no) 1997-10-27

Similar Documents

Publication Publication Date Title
DE69637947D1 (de) Multimerer, rekombinanter urease impfstoff
IL136249A0 (en) Suppository containing an acid-labile active compound
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
GB9820525D0 (en) Formulation
ATE279940T1 (de) Behandlung und prävention von helicobacter- infektionen
IL140140A0 (en) Thyroid hormone analogues and methods for their preparation
BR9806280A (pt) Grânulos compreendendo clavulaneto e um ou mais excipientes
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
DK0579681T3 (da) Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse
NO871599D0 (no) Sammensetning for stimulering av kondrocytter og osteoblaster (osseinhydroksyapatittforbindelse), fremgangsmaate for fremstilling derav og farmasoeytiske preparater inneholdende sammensetningen.
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
EP1073436A4 (de) Verbesserte methode zur ausrottung von helicobacter pylori
DE69923835D1 (de) Makrolid-lhrh-antagonisten
DK0640098T3 (da) S-gen fra hundecoronavirus og anvendelser deraf
AU3322100A (en) Targeted vesicular constructs for cytoprotection and treatment of (h. pylori) infections
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
MX9802809A (es) Ureasa para el tratamiento de infecciones de helicobacter pylori.
NO872331D0 (no) Farmasoeytiske preparater for behandling av bakterielle infeksjoner.
CA2045950A1 (en) Recombinant vaccine for prevention and/or treatment of pleuropneumonia infections
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
DK0874863T3 (da) 3-deoxy-3-descladinose-derivater fra erythromycin A og B
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler
AU8393398A (en) Causative agent of sow abortion and mortality syndrome (sams), vaccine compositions, antibodies and method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties